Loading…
METHOCARBAMOL ARISTO is a brand name for Methocarbamol. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Symptomatic treatment of painful muscle tone, especially in the low back region (lumbago). Methocarbamol is used in adults.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology The dosage for adults is 1500 mg methocarbamol three times a day. For the start of treatment, intake of 1500 mg methocarbamol four times a day is recommended. In the case of severe complaints, patients may take up to 7500 mg methocarbamol per day.
Duration of administration Methocarbamol should be taken for as long as the symptoms induced by increased muscle tone persist, but should not exceed 30 days. Elderly patients Half the maximum dose or less may be sufficient to produce a therapeutic response.
Patients with hepatic impairment In patients with chronic hepatic disease the elimination half-life may be prolonged. Therefore, consideration should be given to increasing the dose interval. Paediatric population The safety and efficacy of Methocarbamol Aristo in children and adolescents have not been established.
Method of administration Methocarbamol Aristo is for oral use. The tablets should be taken with a sufficient amount of water.
g. g. lips and tongue) or the limbs (hands, fingers, feet). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Methocarbamol should be used with special care in patients with impaired renal function and/or impaired liver function. Interference with laboratory tests The urine of some patients receiving methocarbamol has been reported to turn brown, black, blue or green when stored.
Methocarbamol may cause colour interference in certain screening tests for hydroxyindolacetic acid (5-HIAA) and for vanillylmandelic acid (VMA). Methocarbamol Aristo contains sodium This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium- free’.
1, - comatose or pre-comatose states, - diseases of the central nervous system, - Myasthenia gravis, - Patients with a predisposition to epileptic seizures
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Methocarbamol in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.